| Dr Melody Anita Baldwin, MD, MPH | |
|
Office Of Graduate Medical Education, Duke University Hospital, Box 3951, Durham, NC 27710-0001 | |
| (919) 684-3491 | |
| (919) 684-8565 |
| Full Name | Dr Melody Anita Baldwin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | Office Of Graduate Medical Education, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043536907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2014-01709 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke Regional Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
A new study finds that E. coli bacteremia - a potentially life-threatening bloodstream infection caused by a common bacteria also associated with less dangerous urinary tract infections - poses a significant public health threat in the United States, especially among seniors.
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs - environmental pollutants that are one of the most harmful aspects of oil spills.
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
› Verified 3 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
A new study finds that E. coli bacteremia - a potentially life-threatening bloodstream infection caused by a common bacteria also associated with less dangerous urinary tract infections - poses a significant public health threat in the United States, especially among seniors.
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs - environmental pollutants that are one of the most harmful aspects of oil spills.
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
› Verified 3 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
A new study finds that E. coli bacteremia - a potentially life-threatening bloodstream infection caused by a common bacteria also associated with less dangerous urinary tract infections - poses a significant public health threat in the United States, especially among seniors.
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs - environmental pollutants that are one of the most harmful aspects of oil spills.
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melody Anita Baldwin, MD, MPH Office Of Graduate Medical Education, Duke University Hospital, Box 3951, Durham, NC 27710-0001 Ph: (919) 684-3491 | Dr Melody Anita Baldwin, MD, MPH Office Of Graduate Medical Education, Duke University Hospital, Box 3951, Durham, NC 27710-0001 Ph: (919) 684-3491 |
News Archive
Grifols today announced availability of its recently approved Flebogamma® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma. Approval from the US Food and Drug Administration (FDA) for Flebogamma® 10% DIF was obtained in July 2010 and final approval in Europe is expected before the end of the year. Today's announcement signals widespread product availability to the US market.
A new study finds that E. coli bacteremia - a potentially life-threatening bloodstream infection caused by a common bacteria also associated with less dangerous urinary tract infections - poses a significant public health threat in the United States, especially among seniors.
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs - environmental pollutants that are one of the most harmful aspects of oil spills.
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
› Verified 3 days ago
Dr. Anne Ford, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5324 Macfarland Dr Suite 300, Duke Womens Health Associates, Durham, NC 27707 Phone: 919-687-4688 Fax: 919-687-4606 | |
Maria J Small, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Trent Drive, Durham, NC 27710 Phone: 919-684-8111 | |
Jerome Federspiel, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2608 Erwin Rd Ste 200, Durham, NC 27705 Phone: 919-681-5220 | |
Jeffrey Wilkinson, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 | |
Dr. Ryan Timothy Bakelaar, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 122 Eagles Nest Dr, Durham, NC 27712 Phone: 919-383-0875 | |
Megan R. Barrett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd, Durham, NC 27705 Phone: 919-684-8111 Fax: 919-620-4921 |